MINNEAPOLIS, Oct. 18 /PRNewswire-FirstCall/ -- ATS Medical, Inc. today announced that it will release financial results for the third quarter ended September 30, 2006 after market close on Wednesday, November 1st, 2006. The Company will host a conference call and webcast on Wednesday, November 1st, 2006 at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss the Company's third quarter results, outlook for the remainder of 2006, and current corporate developments. The dial-in number for the conference call is 800-257-3401 for domestic participants and 303-205-0044 for international participants.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO )
A taped replay of the conference call will also be available beginning approximately one hour after the call's conclusion and will remain available for seven days. The replay can be accessed by dialing 800-405-2236 for domestic participants and 303-590-3000 for international participants, using the passcode 11074143#. A live webcast of the call can be accessed at http://www.atsmedical.com by clicking on the Investors icon. The webcast will also be archived on the company's website.
About ATS Medical
ATS Medical, Inc. provides innovative products and services focused on cardiac surgery. The company, global in scope, has been headquartered in Minneapolis, Minnesota since its founding in 1991. More than 130,000 ATS Open Pivot(R) Heart Valves, which utilize a unique pivot design resulting in exceptional performance and low risk profile, have been implanted in patients worldwide. The ATS 3f(R) brand encompasses multiple tissue heart valve product offerings at varying steps from market introductions to clinical trials to development projects that incorporate less invasive valve replacement technology. ATS Medical's focus on serving the cardiac surgery community is further strengthened by offerings that include ATS Simulus(TM) annuloplasty products for heart valve repair, SurgiFrost(R) and FrostByte(TM) products for surgical cryoablation of cardiac arrhythmias, RTI-Cardiovascular for allograft tissue services, and the development of PARSUS blood filtration technology. The ATS Medical web site is http://www.atsmedical.com .
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comATS Medical, Inc.CONTACT: Michael Dale, President-CEO of ATS Medical, Inc.,+1-763-553-7736; or Investors, Jennifer Beugelmans, +1-646-277-8704, orDoug Sherk, +1-415-896-6820, or media, Steve DiMattia, +1-646-277-8706, allof EVC Group, Inc.
Web site: http://www.atsmedical.com/
